Page last updated: 2024-08-25

bexarotene and Carcinogenesis

bexarotene has been researched along with Carcinogenesis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Bommi, PV; Borras, E; Bowen, CM; Chang, K; Lynch, PM; Ozcan, Z; Reyes-Uribe, L; Scheet, PA; Sinha, KM; Taggart, MW; Thirumurthi, S; Vilar, E; Walter, L; Wu, W	1
Gudas, LJ; Osei-Sarfo, K; Scognamiglio, T; Tang, XH; Urvalek, AM; Zhang, T	1

Other Studies

2 other study(ies) available for bexarotene and Carcinogenesis

Article	Year
Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis. Cancer prevention research (Philadelphia, Pa.), 2021, Volume: 14, Issue:9 Topics: Adenomatous Polyposis Coli; Adenomatous Polyps; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Carcinogenesis; Case-Control Studies; Cells, Cultured; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Intestinal Neoplasms; Male; Mice; Mice, Transgenic; Sulindac	2021
Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide. Proceedings of the National Academy of Sciences of the United States of America, 2014, Jun-17, Volume: 111, Issue:24 Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Benzoates; beta Catenin; Bexarotene; Carcinogenesis; Carcinogens; Cell Cycle; Cell Proliferation; Drug Screening Assays, Antitumor; Drug Synergism; Esophageal Neoplasms; Female; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mouth Neoplasms; Naphthols; Oxidative Stress; Reactive Oxygen Species; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids; Tetrahydronaphthalenes; Triglycerides	2014

Article

Year

Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.

Cancer prevention research (Philadelphia, Pa.), 2021, Volume: 14, Issue:9

Topics: Adenomatous Polyposis Coli; Adenomatous Polyps; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Carcinogenesis; Case-Control Studies; Cells, Cultured; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Intestinal Neoplasms; Male; Mice; Mice, Transgenic; Sulindac

2021

Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.

Proceedings of the National Academy of Sciences of the United States of America, 2014, Jun-17, Volume: 111, Issue:24

Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Benzoates; beta Catenin; Bexarotene; Carcinogenesis; Carcinogens; Cell Cycle; Cell Proliferation; Drug Screening Assays, Antitumor; Drug Synergism; Esophageal Neoplasms; Female; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mouth Neoplasms; Naphthols; Oxidative Stress; Reactive Oxygen Species; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids; Tetrahydronaphthalenes; Triglycerides

2014